Spitfire List Web site and blog of anti-fascist researcher and radio personality Dave Emory.

Search Results

Your search for '"October Surprise"' returned 51 results.

FTR #899 Fara Mansoor on “The Deep October Surprise,” Part 4

This broad­cast con­cludes our review of Fara Man­soor’s hero­ic, ground-break­ing research on what we call “The Deep Octo­ber Sur­prise,” and ref­er­ences the his­tor­i­cal lessons to be drawn from the inquiry to the con­tem­po­rary polit­i­cal scene. Usu­al­ly, the term “Octo­ber Sur­prise” refers to an alleged deal between the Reagan/Bush cam­paign and the Khome­i­ni regime in Iran to with­hold the U.S. hostages tak­en from the Amer­i­can Embassy until after Jim­my Carter’s humil­i­a­tion and con­se­quent elec­tion defeat were assured. Fara’s research goes far­ther and deep­er, sug­gest­ing that the CIA learned of the Shah’s can­cer in 1974 (from for­mer CIA direc­tor Richard Helms), with­held the infor­ma­tion from Jim­my Carter, installed Khome­ini’s Islam­ic fun­da­men­tal­ists as an anti-com­mu­nist bul­wark on the Sovi­et Union’s South­ern flank and then micro-man­aged the hostage cri­sis to insure the ascen­sion of the Reagan/Bush/Casey forces. What has become known as the Iran-Con­tra Scan­dal was an out­growth of this dynam­ic. In this pro­gram, we flesh out the net­work­ing involv­ing the Shah’s intel­li­gence spe­cial­ist Hos­sein Far­doust, who select­ed the per­son­nel for Khome­ini’s mil­i­tary gen­er­al staff and became the head of his secret police. Anoth­er of the Bush/CIA operatives–Ibrahim Yazdi–helped Khome­i­ni move from Iraq to Paris, served as his de fac­to chief of staff in Paris, served as his PR flack in the U.S., and was instru­men­tal in maneu­ver­ing Mashal­lah Khashani into place as secu­ri­ty coor­di­na­tor for the U.S. Embassy in Teheran. Pro­gram High­lights Include: Khashani’s lead­er­ship in the takeover of the U.S. Embassy in Novem­ber of 1979; the par­tial dis­arm­ing of the Marine guards at the embassy pri­or to the takeover; a pri­or takeover attempt on 2/14/1979 by Khome­i­ni forces dis­guised as “left­ists;” net­work­ing between some of Far­doust’s selec­tions for Khome­ini’s gen­er­al staff and promi­nent fig­ures in the Iran-Con­tra scan­dal; the counter-ter­ror­ism back­ground of Lin­da Tripp, the Bush White House holdover who helped de-sta­bi­lize the Bill Clin­ton admin­is­tra­tion; Mitt Rom­ney backer and FBI direc­tor James Comey’s ini­ti­a­tion of the inves­ti­ga­tion of Hillary Clin­ton’s e‑mail serv­er.

FTR #898 Fara Mansoor on “The Deep October Surprise,” Part 3

With the recent Iran­ian nuclear deal and the lift­ing of eco­nom­ic sanc­tions against Iran, the his­to­ry of U.S./Iranian rela­tions has attained greater rel­e­vance. In that con­text, we present the third of sev­er­al shows revis­it­ing Fara Man­soor’s land­mark research on what we have termed the “Deep Octo­ber Sur­prise.” Fara’s research sug­gests that the CIA learned of the Shah’s can­cer in 1974 (from for­mer CIA direc­tor Richard Helms), with­held the infor­ma­tion from Jim­my Carter, installed Khome­ini’s Islam­ic fun­da­men­tal­ists as an anti-com­mu­nist bul­wark on the Sovi­et Union’s South­ern flank and then micro-man­aged the hostage cri­sis to insure the ascen­sion of the Reagan/Bush/Casey forces. After a series of vio­lent inci­dents that sowed chaos in Iran, the Shah him­self real­ized that U.S. intel­li­gence was engi­neer­ing his removal. ” . . . . By late August [of 1977], the Shah was total­ly con­fused. U.S. Ambas­sador Sul­li­van record­ed the Shah’s plead­ings over the out­break of vio­lence: ‘He said the pat­tern was wide­spread and that it was like an out­break of a sud­den rash in the country…it gave evi­dence of sophis­ti­cat­ed plan­ning and was not the work of spon­ta­neous oppositionists…the Shah pre­sent­ed that it was the work of for­eign intrigue…this intrigue went beyond the capa­bil­i­ties of the Sovi­et KGB and must, there­fore, also involve British and Amer­i­can CIA. The Shah went on to ask ‘Why was the CIA sud­den­ly turn­ing against him? What had he done to deserve this sort of action from the Unit­ed States?’ . . . .” Pro­gram High­lights Include: the dis­ap­pear­ance and prob­a­ble assas­si­na­tion in Libya of a key Shi­ite cler­i­cal rival of Khomeini’s–Ayatollah Mosa Sadr; a provo­ca­tion in which a the­ater was burned down, killing 750 occupants–an attack blamed on the SAVAK and the Shah; an arti­cle placed in an Iran­ian paper that inflamed the pop­u­lace against the Shah and coa­lesced the Shi­ite cler­gy against him; key Shah aide Gen­er­al Hos­sein Far­doust’s author­ship of the provoca­tive arti­cle; the piv­otal role played in “the Deep Octo­ber Sur­prise” by Dr. Ibrahim Yaz­di; the Nazi intel­li­gence back­ground of Fazol­lah Zahe­di, who replaced Mohammed Mossadegh after the CIA coup in 1953.

FTR #897 Fara Mansoor on the “Deep October Surprise,” Part 2

This broad­cast is the sec­ond of sev­er­al pro­grams review­ing and high­light­ing mate­r­i­al first pre­sent­ed in ear­ly 1993, fea­tur­ing the land­mark research of Fara Man­soor, a hero­ic, long­time mem­ber of the Iran­ian resis­tance. Usu­al­ly, the term “Octo­ber Sur­prise” refers to an allege deal between the Reagan/Bush cam­paign and the Khome­i­ni regime in Iran to with­hold the U.S. hostages tak­en from the Amer­i­can Embassy until after Jim­my Carter’s humil­i­a­tion and con­se­quent elec­tion defeat were assured. Fara’s research goes far­ther and deep­er, sug­gest­ing that the CIA learned of the Shah’s can­cer in 1974 (from for­mer CIA direc­tor Richard Helms), with­held the infor­ma­tion from Jim­my Carter, installed Khome­ini’s Islam­ic fun­da­men­tal­ists as an anti-com­mu­nist bul­wark on the Sovi­et Union’s South­ern flank and then micro-man­aged the hostage cri­sis to insure the ascen­sion of the Reagan/Bush/Casey forces. What has become known as the Iran-Con­tra Scan­dal was an out­growth of this dynam­ic. In this pro­gram we present analy­sis of the first phase(s) of the oper­a­tion, not­ing that for­mer CIA direc­tor Richard Helms learned of the Shah’s can­cer in 1975 from Gen­er­al Hos­sein Far­doust. With­hold­ing this infor­ma­tion from Pres­i­dent Carter, the CIA fed the admin­is­tra­tion dis­in­for­ma­tion assert­ing that the Shah’s reign well into the 1980’s was assured. Mean­while, the Agency was maneu­ver­ing to install Khome­i­ni as a bul­wark against the left, and, as we shall see, a vehi­cle to desta­bi­lize the Carter admin­is­tra­tion and guar­an­tee the vic­to­ry of the Reagan/Bush team in the 1980 elec­tions. Pro­gram High­lights Include: the pres­ence in Iran in April of 1978 of George H.W. Bush, Ronald Rea­gan and Mar­garet Thatch­er; the long asso­ci­a­tion of the Shah-to-be, Richard Helms and Gen­er­al Hos­sein Far­doust dat­ing to their days togeth­er in a Swiss board­ing school; Carter’s “Hal­loween mas­sacre” in which he fired some 800 CIA covert oper­a­tors, who coa­lesced as part of the Bush team that installed Khome­i­ni and the fun­da­men­tal­ists in pow­er.

FTR #896 Fara Mansoor on “The Deep October Surprise,” Part 1

This broad­cast begins sev­er­al pro­grams review­ing and high­light­ing mate­r­i­al first pre­sent­ed in ear­ly 1993, fea­tur­ing the land­mark research of Fara Man­soor, a long­time, hero­ic mem­ber of the Iran­ian resis­tance. Usu­al­ly, the term “Octo­ber Sur­prise” refers to an alleged deal between the Reagan/Bush cam­paign and the Khome­i­ni regime in Iran to with­hold the U.S. hostages tak­en from the Amer­i­can Embassy until after Jim­my Carter’s humil­i­a­tion and con­se­quent elec­tion defeat were assured. Fara’s research goes far­ther and deep­er, sug­gest­ing that the CIA learned of the Shah’s can­cer in 1974 (from for­mer CIA direc­tor Richard Helms), with­held the infor­ma­tion from Jim­my Carter, installed Khome­ini’s Islam­ic fun­da­men­tal­ists as an anti-com­mu­nist bul­wark on the Sovi­et Union’s South­ern flank and then micro-man­aged the hostage cri­sis to insure the ascen­sion of the Reagan/Bush/Casey forces. What has become known as the Iran-Con­tra Scan­dal was an out­growth of this dynam­ic. In this pro­gram, we begin our analy­sis with an overview of the covert oper­a­tion, both in the U.S. and Iran, high­light­ing the key play­ers and the net­work­ing in which they engaged to ensure Carter’s down­fall and Khome­ini’s rise to pow­er. Of par­tic­u­lar inter­est is the “deep-net­work­ing” between U.S. oper­a­tives such as Richard Cot­tam and Iran­ian agents such as Gen­er­al Hos­sein Far­doust and Vial­lol­lah Qarani. Cot­tam, Far­doust and Qarani’s asso­ci­a­tion stretch from the 1953 coup that installed the Shah and the 1979 “op” that installed Khome­i­ni in Iran and the Reagan/Bush team in the U.S. The pro­gram high­lights the extent to which Amer­i­can domes­tic pol­i­tics, nation­al secu­ri­ty pol­i­cy and over­seas diplo­ma­cy are con­trolled by what amounts to a “secret state.”

FTR #735 Bay of Pigs Meets the October Surprise: Lee Harvey Obama and the Piggy Back Coup in the Middle East

U.S. backed and helped launch the over­throw of Mubarak;Operation was begun under Bush with Oba­ma poised to take the blame for “los­ing the Mid­dle East”; Mus­lim Broth­er­hood, Karl Rove, GOP, transna­tion­al cor­po­rate and Under­ground Reich ele­ments poised to take advan­tage.

Latest Patreon Uploads: The Making of Japan, Inc., Lab Leak Covid Meme, Spreading Bank Crisis, World War III, 1934 Coup Attempt Revisited

The lat­est Patre­on talks–with machine transcriptions–include top­ics such as the insti­tu­tion­al links between the 1934 Coup Attempt and the cap­i­tal­iza­tion of Japan before and after World War II; Sim­i­lar­i­ties between Japan Inc. and Amer­i­ca Inc.; Pro­pa­gan­diz­ing of the “Lab Leak” pro­pa­gan­da meme in Covid. Dr. Jef­frey Sachs “pret­ty con­vinced” Covid came from a U.S. Bio-Lab. WFMU-FM is pod­cast­ing For The Record–You can sub­scribe to the pod­cast HERE. Mr. Emory emphat­i­cal­ly rec­om­mends that listeners/readers get the 32GB flash dri­ve con­tain­ing all of Mr. Emory’s 43 years on the air, plus a library of old anti-fas­cist books on easy-to-down­load PDF files.

FTR #1134 Bio-Psy-Op Apocalypse Now, Part 9: Covid-19 Updates

As indi­cat­ed by the title of the pro­gram, this broad­cast updates var­i­ous arti­cles and book excerpts con­cern­ing Covid-19.

A Dai­ly Mail Online [UK] arti­cle sets forth two bogus papers con­tend­ing that the SARS CoV‑2 virus was genet­i­cal­ly engi­neered by the Chi­nese as a bioweapon in a lab­o­ra­to­ry and that it “escaped.” Note the cham­pi­oning of one of the papers by a for­mer head of MI6 and the author­ship of the sec­ond by The Epoch Times, the paper of the Falun Gong cult. Linked to CIA, Steve Ban­non’s anti-Chi­na milieu and the Trump admin­is­tra­tion, the orga­ni­za­tion is a fas­cist mind con­trol cult dis­cussed in numer­ous shows, includ­ing FTR #‘s 1089 and 1090. 

1.–“A for­mer MI6 chief was yes­ter­day accused by Gov­ern­ment offi­cials of ped­dling ‘fan­ci­ful claims’ that coro­n­avirus was acci­den­tal­ly cre­at­ed in a Chi­nese lab­o­ra­to­ry. British secu­ri­ty agen­cies believe Covid-19 is not a man-made virus and is ‘high­ly like­ly’ to have occurred nat­u­ral­ly and spread to humans through ani­mals. And Health Sec­re­tary Matt Han­cock has said there is ‘no evi­dence’ to back up the the­o­ry that it orig­i­nat­ed in a lab­o­ra­to­ry. But Sir Richard Dearlove, who was head of the MI6 from 1999 to 2004, cit­ed a recent report claim­ing the dis­ease was acci­den­tal­ly man­u­fac­tured by Chi­nese sci­en­tists.
2.–“ ‘I do think that this start­ed as an acci­dent,’ Sir Richard told The Dai­ly Telegraph’s ‘Plan­et Nor­mal’ pod­cast. ‘It rais­es the issue: if Chi­na ever were to admit respon­si­bil­i­ty, does it pay repa­ra­tions? I think it will make every coun­try in the world rethink how it treats its rela­tion­ship with Chi­na.’ He added: ‘Look at the sto­ries... of attempts by the [Bei­jing] lead­er­ship to lock down any debate about the ori­gins of the pan­dem­ic and the way peo­ple have been arrest­ed or silenced.’ . . . . The paper – co-authored by Pro­fes­sor Angus Dal­gleish, a renowned oncol­o­gist and vac­cine researcher who works at St George’s Hos­pi­tal, Uni­ver­si­ty of Lon­don, and Birg­er Sorensen, a Nor­we­gian virol­o­gist – con­tains none of the stark alle­ga­tions that orig­i­nal­ly stunned its review­ers.
3..–“The ini­tial paper that trig­gered wild rumours failed strin­gent tests of ver­i­fi­ca­tion and is under­stood to have been reject­ed in April by emi­nent inter­na­tion­al jour­nals such as Nature and the Jour­nal of Virol­o­gy. Bio­med­ical experts from the Fran­cis Crick Insti­tute and Impe­r­i­al Col­lege Lon­don are said to have refut­ed its con­clu­sions. Then one of the paper’s co-authors, Dr John Fredrik Moxnes, chief sci­en­tif­ic advis­er to the Nor­we­gian mil­i­tary, asked for his name to be with­drawn. This week, after numer­ous rewrites, the paper was pub­lished by the Quar­ter­ly Review of Bio­physics Dis­cov­ery. And those orig­i­nal world-shak­ing con­clu­sions have now with­ered to innu­en­do. No accu­sa­tion of Chi­nese manip­u­la­tion appears. . . .”
4.–”. . . . Back in April, a slick­ly pro­duced inves­tiga­tive doc­u­men­tary, Track­ing Down The Ori­gin Of The Wuhan Coro­n­avirus, was released online. It claimed con­clu­sive proof that the Covid-19 virus had been cre­at­ed as a bio­log­i­cal ‘weapon of mass destruc­tion’ in a Chi­nese lab. . . .”
5.–“At first sight, it seemed a shock­ing­ly con­vinc­ing piece of jour­nal­ism. On behalf of this news­pa­per, I cross-checked every claim: The experts it cit­ed and the fac­tu­al evi­dence unearthed. I also researched the back­grounds of its mak­ers. I then approached some of the world’s best inde­pen­dent sci­en­tif­ic author­i­ties to ask their opin­ion. They all agreed – this entic­ing­ly spicy sto­ry just did­n’t stand up.”
6.–“It had been pro­duced by a US based anti-Chi­nese gov­ern­ment media organ­i­sa­tion called the Epoch Times. Its ‘experts’ were vet­er­an hard-Right­ists. Most damn­ing­ly, its sci­en­tif­ic ‘facts’ were twist­ed out of shape.So much, then, for the Chi­nese-man­u­fac­tured coro­n­avirus con­spir­a­cy . . .”

Steve Ban­non is at the epi­cen­ter of the anti-Chi­na effort and–to no one’s surprise–never real­ly left the Trump White House.

When assess­ing Ban­non as a polit­i­cal ani­mal, one should nev­er for­get that among the impor­tant ide­o­log­i­cal influ­ences on him is Julius Evola, an Ital­ian fas­cist who found Mus­soli­ni too mod­er­ate and ulti­mate­ly took his cues from the Nazi SS, who were financ­ing his work by the end of World War II.

” . . . . Don­ald Trump’s light­ning-rod 2016 cam­paign boss and for­mer White House chief strate­gist who was ban­ished from the West Wing in 2017 has qui­et­ly crept back into 1600 Penn­syl­va­nia Ave., reestab­lish­ing ties to staffers, par­tic­u­lar­ly with regard to his pet issues of Chi­na and immi­gra­tion. . . . Anoth­er for­mer admin­is­tra­tion offi­cial told The Post that Ban­non nev­er real­ly left the White House after he was fired, main­tain­ing con­tacts and keep­ing up reg­u­lar chan­nels of com­mu­ni­ca­tions with offi­cials there. . . .”

In addi­tion, as dis­cussed in FTR #‘s 1111 and 1112, Ban­non is part of a net­work that includes J. Kyle Bass and Tom­my Hicks, Jr. This nexus involves asym­met­ri­cal invest­ing with regard to the Hong Kong and Chi­nese economies and the inter-agency gov­ern­men­tal net­works involved in both overt and covert anti-Chi­na poli­cies imple­ment­ed by Team Trump. As will be seen below, they also are net­work­ing with the mis-named “Sci­en­tists to Stop Covid-19.” In that regard, they are also help­ing steer pol­i­cy that con­trols devel­op­ment of treat­ment and vac­cines for Covid-19. The man­age­ment of drug and vac­cine devel­op­ment, in turn, dou­bles back to mar­ket-dri­ving invest­ment dynam­ics.

An inter­est­ing sum­ma­tion of char­ac­ter­is­tics of a “delib­er­ate” epi­dem­ic are eval­u­at­ed against the find­ing that New York City was the epi­cen­ter of the U.S. Covid-19 out­break: 

Bit­ten: The Secret His­to­ry of Lyme Dis­ease and Bio­log­i­cal Weapons by Kris New­by; Harper­Collins [HC]; Copy­right 2019 by Kris New­by; ISBN 9780062896728; p. 185.

Poten­tial epi­demi­o­log­i­cal clues to a delib­er­ate epi­dem­ic:

Clue no. 1–A high­ly unusu­al event with large num­bers of casu­al­ties: Check!

Clue no. 2–Higher mor­bid­i­ty or mor­tal­i­ty than is expect­ed. Check!

Clue no. 3–Uncommon dis­ease. Check!

Clue no. 4–Point-source out­break. Check!

Clue no. 5–Multiple epi­demics. Check! (Glob­al pan­dem­ic)

                      –Z. F. Dem­bek, et al., “Dis­cern­ment Between Delib­er­ate and Nat­ur­al Infec­tious Dis­ease Out­breaks”

The pre­vail­ing view of the Covid-19 out­break con­tends that the Amer­i­can out­break spread out­ward from New York City. The strain of SARS CoV‑2 that appeared in New York came, in turn, from Europe. 

This does­n’t make sense. There were con­firmed cas­es of the virus on the West Coast that did not come from New York. A Euro­pean strain of the virus trans­mit­ted to New York City would have come in via air. In such an event, there would have been a well-doc­u­ment­ed out­break of Covid-19 among flight atten­dants, who oper­ate in close con­tact with pas­sen­gers in cramped cir­cum­stances, as well as expe­ri­enc­ing jet lag, which com­pro­mis­es the immune sys­tem.

Next, we review an aspect of the 2001 anthrax attacks. We high­light­ed the 2001 anthrax attacks in con­nec­tion with the Covid-19 out­break in New York City in FTR #1128.

We note that the Anthrax attacks appear to have oper­at­ed in over­lap­ping con­texts, includ­ing jus­ti­fi­ca­tion for the war in Iraq. 

The 2001 anthrax attacks appear to have served as a provo­ca­tion that jus­ti­fied a ten-fold increase in spend­ing for bio­log­i­cal war­fare devel­op­ment. The num­ber of BSL‑4 labs (hav­ing dual civil­ian and mil­i­tary use) increased from two in 2001, to a dozen in 2007.

This increase occurred while Don­ald Rums­feld was George W. Bush’s sec­re­tary of defense. He went to that posi­tion from being Chair­man of the Board of Direc­tors for Gilead Sci­ences, the man­u­fac­tur­er of remde­sivir.

We will delve into the pol­i­tics of the anthrax attacks in the future.

In the con­text of the above arti­cle, note that the Nation­al Insti­tutes of Health have also part­nered with CIA and the Pen­ta­gon, as under­scored by an arti­cle about a BSL‑4 lab at Boston Uni­ver­si­ty. Note that Europe and the U.S. have twelve BSL4 labs apiece. Tai­wan has two. Chi­na has one:

1.–As the arti­cle notes, as of 2007, the U.S. had “more than a dozen” BSL4 labs–China com­mis­sioned its first as of 2017. a ten­fold increase in fund­ing for BSL4 labs occurred because of the anthrax attacks of 2001. Those attacks might be seen as some­thing of a provo­ca­tion, spurring a dra­mat­ic increase in “dual use” biowar­fare research, under the cov­er of “legit­i­mate” medical/scientific research. In FTR #1128, we hypoth­e­sized about the milieu of Stephen Hat­fill and apartheid-linked inter­ests as pos­si­ble authors of a vec­tor­ing of New York City with Sars COV2: ” . . . . Before the anthrax mail­ings of 2001, the Unit­ed States had just two BSL4 labs—both with­in the razor-wire con­fines of gov­ern­ment-owned cam­pus­es. Now, thanks to a ten­fold increase in funding—from $200 mil­lion in 2001 to $2 bil­lion in 2006—more than a dozen such facil­i­ties can be found at uni­ver­si­ties and pri­vate com­pa­nies across the coun­try. . . .”
2.–The Boston Uni­ver­si­ty lab exem­pli­fies the Pen­ta­gon and CIA pres­ence in BSL‑4 facil­i­ty “dual use”: ” . . . . But some sci­en­tists say that argu­ment obscures the true pur­pose of the cur­rent biode­fense boom: to study poten­tial bio­log­i­cal weapons. ‘The uni­ver­si­ty por­trays it as an emerg­ing infec­tious dis­ease lab,’ says David Ozonoff, a Boston Uni­ver­si­ty epi­demi­ol­o­gist whose office is right across the street from the new BSL4 facil­i­ty. ‘But they are talk­ing about study­ing things like small pox and inhala­tion anthrax, which pose no pub­lic health threat oth­er than as bioweapons.’ . . . The orig­i­nal NIH man­date for the lab indi­cat­ed that many groups—including the CIA and Depart­ment of Defense—would be allowed to use the lab for their own research, the nature of which BU might have lit­tle con­trol over. . . .”

Piv­ot­ing to dis­cus­sion and review of the polit­i­cal, finan­cial and cor­po­rate con­nec­tions to the devel­op­ment of med­i­c­i­nal treat­ments for, and vac­cines to pre­vent, Covid-19, we recap details rel­e­vant to the extra­or­di­nary tim­ing of a 4/29 announce­ment of favor­able results for a tri­al of remde­sivir. That announce­ment drove equi­ties mar­kets high­er and was ben­e­fi­cial to the stock of Gilead Sci­ences.

We present a Stat News arti­cle on the inter­nal delib­er­a­tions behind the deci­sions to mod­i­fy the NIAID study. Of par­tic­u­lar sig­nif­i­cance is the DSMB delib­er­a­tion. Note the time­line of the DSMB delib­er­a­tion, com­bined with the announce­ment on 4/29 that drove the mar­kets high­er.

1.–The deci­sion was made to cut it short before the ques­tion of remdesivir’s impact on mor­tal­i­ty could be answered: ” . . . .The Nation­al Insti­tute of Aller­gy and Infec­tious Dis­eases has described to STAT in new detail how it made its fate­ful deci­sion: to start giv­ing remde­sivir to patients who had been assigned to receive a place­bo in the study, essen­tial­ly lim­it­ing researchers’ abil­i­ty to col­lect more data about whether the drug saves lives — some­thing the study, called ACTT‑1, sug­gests but does not prove. In the tri­al, 8% of the par­tic­i­pants giv­en remde­sivir died, com­pared with 11.6% of the place­bo group, a dif­fer­ence that was not sta­tis­ti­cal­ly sig­nif­i­cant. A top NIAID offi­cial said he had no regrets about the deci­sion. ‘There cer­tain­ly was una­nim­i­ty with­in the insti­tute that this was the right thing to do,’ said H. Clif­ford Lane, NIAID’s clin­i­cal direc­tor. . . .”
2.–In addi­tion, patients sched­uled to receive place­bo received remde­sivir, instead. ” . . . . Steven Nis­sen, a vet­er­an tri­al­ist and car­di­ol­o­gist at the Cleve­land Clin­ic, dis­agreed that giv­ing place­bo patients remde­sivir was the right call. ‘I believe it is in society’s best inter­est to deter­mine whether remde­sivir can reduce mor­tal­i­ty, and with the release of this infor­ma­tion doing a place­bo-con­trolled tri­al to deter­mine if there is a mor­tal­i­ty ben­e­fit will be very dif­fi­cult,’ he said. ‘The ques­tion is: Was there a route, or is there a route, to deter­mine if the drug can pre­vent death?’ The deci­sion is ‘a lost oppor­tu­ni­ty,’ he said. . . .”
3.–Steven Nis­sen was not alone in his crit­i­cism of the NIAID’s deci­sion. ” . . . .Peter Bach, the direc­tor of the Cen­ter for Health Pol­i­cy and Out­comes at Memo­r­i­al Sloan Ket­ter­ing Can­cer Cen­ter, agreed with Nis­sen. ‘The core under­stand­ing of clin­i­cal research par­tic­i­pa­tion and clin­i­cal research con­duct is we run the tri­al rig­or­ous­ly to pro­vide the most accu­rate infor­ma­tion about the right treat­ment,’ he said. And that answer, he argued, should ide­al­ly have deter­mined whether remde­sivir saves lives. The rea­son we have shut our whole soci­ety down, Bach said, is not to pre­vent Covid-19 patients from spend­ing a few more days in the hos­pi­tal. It is to pre­vent patients from dying. ‘Mor­tal­i­ty is the right end­point,’ he said. . . .”
4.–Not only was the admin­is­tra­tion of remde­sivir instead of place­bo pri­or­i­tized, but the NIAID study itself was atten­u­at­ed! ” . . . . But the change in the study’s main goal also changed the way the study would be ana­lyzed. Now, the NIAID decid­ed, the analy­sis would be cal­cu­lat­ed when 400 patients out of the 1,063 patients the study enrolled had recov­ered. If remde­sivir turned out to be much more effec­tive than expect­ed, ‘inter­im’ analy­ses would be con­duct­ed at a third and two-thirds that number.The job of review­ing these analy­ses would fall to a com­mit­tee of out­side experts on what is known as an inde­pen­dent data and safe­ty mon­i­tor­ing board, or DSMB. . . .”
5.–The per­for­mance of the DSMB for the remde­sivir study is note­wor­thy: ” . . . . But the DSMB for the remde­sivir study did not ever meet for an inter­im effi­ca­cy analy­sis, Lane said. All patients had been enrolled by April 20. The data for a DSMB meet­ing was cut off on April 22. The DSMB met and, on April 27, it made a rec­om­men­da­tion to the NIAID. . . .”
The DSMB meet­ing on 4/27 deter­mined the switch from place­bo to remde­sivir. Of para­mount impor­tance is the fact that this was JUST BEFORE the 4/29 announce­ment that drove the mar­kets high­er and the same day on which key Trump aide–and for­mer Gilead Sci­ences lob­by­ist Joe Gro­gan resigned! ” . . . . . That deci­sion, Lane said, led the NIAID to con­clude that patients who had been giv­en place­bo should be offered remde­sivir, some­thing that start­ed hap­pen­ing after April 28. . . .”
6.–Dr. Ethan Weiss gave an accu­rate eval­u­a­tion of the NIAID study: ” . . . . ‘We’ve squan­dered an incred­i­ble oppor­tu­ni­ty to do good sci­ence,’ [Dr. Ethan] Weiss said. ‘If we could ever go back and do some­thing all over, it would be the infra­struc­ture to actu­al­ly learn some­thing. Because we’re not learn­ing enough.’ . . . .”

The remark­able han­dling of the NIAID study, the tim­ing of the announce­ment of the alto­geth­er lim­it­ed suc­cess of the atten­u­at­ed tri­al and the rise in equi­ties as a result of the announce­ment may be best under­stood in the con­text of the role played in Trump pan­dem­ic deci­sion-mak­ing by an elite group of bil­lion­aires and scientists–including con­vict­ed felon Michael Milken (the “junk bond king”).

1.–” . . . . Call­ing them­selves ‘Sci­en­tists to Stop COVID-19,’ the col­lec­tion of top researchers, bil­lion­aires and indus­try cap­tains will act as an ‘ad hoc review board’ for the tor­rent of coro­n­avirus research, ‘weed­ing out’ flawed data before it reach­es pol­i­cy­mak­ers, the Wall Street Jour­nal report­ed on Mon­day. They are also act­ing as a go-between for phar­ma­ceu­ti­cal com­pa­nies seek­ing to build a com­mu­ni­ca­tion chan­nel with Trump admin­is­tra­tion offi­cials. The group . . . . has advised Nick Ayers, an aide to Vice Pres­i­dent Mike Pence, as well as oth­er agency heads, in the past month. Pence is head­ing up the White House coro­n­avirus task force. . . .”
2.–” . . . The brainy bunch is led by Thomas Cahill, a 33-year-old doc­tor who became a ven­ture cap­i­tal­ist . . . . Cahill’s clout comes from build­ing con­nec­tions through his invest­ment firm, New­path Part­ners, with Sil­i­con Valley’s Peter Thiel, the founder of Pay­Pal, and bil­lion­aire busi­ness­men Jim Palot­ta and Michael Milken. . . .”

Note that Peter Thiel played a dom­i­nant role in bankrolling New­path Part­ners, and the oth­er finan­cial angel who ele­vat­ed Cahill–Brian Sheth–introduced him to Tom­my Hicks, Jr., the co-chair­man of the RNC. In FTR #‘s 1111 and 1112, we looked at Hicks’ net­work­ing with Steve Ban­non asso­ciate J. Kyle Bass, as well as his role in the inter-agency net­works dri­ving the anti-Chi­na effort.

” . . . . At the helm of the effort: The 33-year-old and very-much-under-the-radar ven­ture cap­i­tal­ist Tom Cahill, who leads life sci­ences-focused New­path Part­ners. Cahill com­plet­ed his M.D. and PhD at Duke Uni­ver­si­ty a mere two years ago before land­ing at blue-chip invest­ment firm Rap­tor Group through a friend. He went on to found New­path with some $125 mil­lion after impress­ing well-con­nect­ed names like ven­ture cap­i­tal­ist Peter Thiel and Vista Equi­ty Part­ners co-founder Bri­an Sheth. . . . It was through Sheth, for exam­ple, that Sci­en­tists to Stop Covid-19 con­nect­ed with the co-chair­man of the Repub­li­can Nation­al Com­mit­tee, Thomas Hicks Jr. . . .”

The fed­er­al gov­ern­men­t’s extreme focus on remde­sivir has been shaped, in large mea­sure, by the influ­ence of “Sci­en­tists to Stop COVID-19”:

1.–“Scientists to Stop Covid-19” is shep­herd­ing remde­sivir: ” . . . . Sci­en­tists to Stop COVID-19 rec­om­mends that in this phase, the U.S. Food and Drug Admin­is­tra­tion (FDA) should work to coor­di­nate with Gilead phar­ma­ceu­ti­cals to focus on expe­dit­ing the results of clin­i­cal tri­als of remde­sivir, a drug iden­ti­fied as a poten­tial treat­ment for COVID-19. The group also rec­om­mends admin­is­ter­ing dos­es of the drug to patients in an ear­ly stage of infec­tion, and notes remde­sivir will essen­tial­ly be a place­hold­er until a more effec­tive treat­ment is pro­duced.
2.–The group is doing so by atten­u­at­ing the reg­u­la­to­ry process for coro­n­avirus drugs: “Gov­ern­ment enti­ties and agen­cies appear to adhere to the rec­om­men­da­tions out­lined by the group, with the Jour­nal report­ing that the FDA and the Depart­ment of Vet­er­ans Affairs (VA) have imple­ment­ed some of the sug­ges­tions, name­ly relax­ing drug man­u­fac­tur­er reg­u­la­tions and require­ments for poten­tial coro­n­avirus treat­ment drugs. . . .”

We con­clude dis­cus­sion of the remde­sivir machi­na­tions with a piece about the tim­ing of the announce­ment of Grogan’s depar­ture.

” . . . . Gro­gan has served as the direc­tor of the White House Domes­tic Pol­i­cy Coun­cil since Feb­ru­ary 2019, over­see­ing a broad array of pol­i­cy issues includ­ing health care and reg­u­la­tion. . . . Gro­gan was one of the orig­i­nal mem­bers of the White House coro­n­avirus task force launched in late Jan­u­ary. . . . Gro­gan worked as a lob­by­ist for drug com­pa­ny Gilead Sci­ences before join­ing the Trump admin­is­tra­tion. . . .”

The depar­ture was announced in the Wall Street Jour­nal on the morn­ing of Wednes­day, April 29, the same day we got our first pub­lic reports of the NIAID clin­i­cal tri­al of remde­sivir that was pos­i­tive enough to show it short­ened the time to recov­ery and the same day the FDA grant­ed remde­sivir emer­gency use sta­tus. 

Note, again, the tim­ing of the DSM­B’s actions, as well as the influ­ence of “Sci­en­tists to Stop Covid-19.”

In FTR #1130, we not­ed that Mon­cef Slaoui–formerly in charge of prod­uct devel­op­ment for Moderna–was cho­sen to head Trump’s “Oper­a­tion Warp Speed.” He will be work­ing with Four-Star Gen­er­al Gus­tave Per­na, cho­sen by Chair­man of the Joint Chiefs of Staff Gen­er­al Mark Mil­ley.

Even after agree­ing to sell his Mod­er­na stock, Mon­cef Slaoui’s invest­ments raise alarm­ing questions–note that he is a “ven­ture cap­i­tal­ist” and a long­time for­mer exec­u­tive at Glaxo-Smithk­line:

The cir­cum­stances of his appoint­ment will per­mit him to avoid scruti­ny: ” . . . . In agree­ing to accept the posi­tion, Dr. Slaoui did not come on board as a gov­ern­ment employ­ee. Instead, he is on a con­tract, receiv­ing $1 for his ser­vice. That leaves him exempt from fed­er­al dis­clo­sure rules that would require him to list his out­side posi­tions, stock hold­ings and oth­er poten­tial con­flicts. And the con­tract posi­tion is not sub­ject to the same con­flict-of-inter­est laws and reg­u­la­tions that exec­u­tive branch employ­ees must fol­low. . . .”
He will retain a great deal of Glaxo-Smithk­line stock: ” . . . . He did not say how much his GSK shares were worth. When he left the com­pa­ny in 2017, he held about [500,000 in West­ern Print Edi­tion] 240,000 shares and share equiv­a­lents, accord­ing to the drug company’s annu­al report and an analy­sis by the exec­u­tive com­pen­sa­tion firm Equi­lar. . . .”
Fur­ther analy­sis of Slaoui’s posi­tion deep­ens con­cern about the integri­ty of the process: ” . . . . ‘This is basi­cal­ly absurd,’ said Vir­ginia Can­ter, who is chief ethics coun­sel for Cit­i­zens for Respon­si­bil­i­ty and Ethics in Wash­ing­ton. ‘It allows for no pub­lic scruti­ny of his con­flicts of inter­est.’ Ms. Can­ter also said fed­er­al law barred gov­ern­ment con­trac­tors from super­vis­ing gov­ern­ment employ­ees. . . . Ms. Can­ter, a for­mer ethics lawyer in the Oba­ma and Clin­ton admin­is­tra­tions, the Secu­ri­ties and Exchange Com­mis­sion and oth­er agen­cies, point­ed out that GSK’s vac­cine can­di­date with Sanofi could wind up com­pet­ing with oth­er man­u­fac­tur­ers vying for gov­ern­ment approval and sup­port. ‘If he retains stock in com­pa­nies that are invest­ing in the devel­op­ment of a vac­cine, and he’s involved in over­see­ing this process to select the safest vac­cine to com­bat Covid-19, regard­less of how won­der­ful a per­son he is, we can’t be con­fi­dent of the integri­ty of any process in which he is involved,’ Ms. Can­ter said.In addi­tion, his affil­i­a­tion with Medicxi could com­pli­cate mat­ters: Two of its investors are GSK and a divi­sion of John­son & John­son, which is also devel­op­ing a poten­tial vac­cine. . . .”

Next, we turn to Mod­er­na’s ani­mal tri­al for the mes­sen­ger RNA vac­cine it is devel­op­ing. There are sev­er­al con­sid­er­a­tions to be weighed in con­nec­tion with the Mod­er­na vac­cine.

1.–Again, the chair­man of Trump’s “Warp Speed” vac­cine devel­op­ment program–Moncef Slaoui–was in charge of Mod­er­na’s prod­uct devel­op­ment oper­a­tion.
2.–Moderna’s tri­al with mice was pos­i­tive with regard to gen­er­at­ing anti­body lev­els high enough to pre­vent ADE.
3.–Antibody Depen­dent Enhance­ment (ADE),  is a phe­nom­e­na where low lev­els of inef­fec­tive anti­bod­ies latch onto the virus and exac­er­bate an over­ac­tive immune response that leads to the dead­liest symp­toms likes cytokine-storms. This dan­ger was seen with SARS and attempts to cre­ate a SARS vac­cine so it’s a rea­son­able fear with SARS-CoV­‑2.
4.–The Phase III (human) tri­al is going to be start­ed in July, involv­ing 30,000 peo­ple. Alarm­ing­ly, those 30,000 peo­ple will all be receiv­ing the exact same dosage, 100 micro­grams, and that means the phase III tri­al won’t be test­ing sub-opti­mal dosages. The big Phase III tri­al won’t be test­ing for ADE in humans. 
5.–We may have a night­mare sit­u­a­tion where polit­i­cal pres­sure gives undo weight to ani­mal safe­ty results, leapfrog­ging over the neces­si­ty of test­ing for side effects. 
6.–The ani­mal tri­als have been severe­ly crit­i­cized: ” . . . . ‘This is the barest begin­ning of pre­lim­i­nary infor­ma­tion,’ said Dr. Gre­go­ry Poland, an immu­nol­o­gist and vac­cine researcher at the Mayo Clin­ic who has seen the paper, which has yet to under­go peer-review. Poland said the paper was incom­plete, dis­or­ga­nized and the num­bers of ani­mals test­ed were small. . . . Poland, who was not involved with the research, said the paper leaves out ‘impor­tant para­me­ters’ that could help sci­en­tists judge the work. . . .”
7.–We MIGHT cre­ate a vac­cine that pro­tects those who get a strong immune response while endan­ger­ing those with sub-pro­tec­tive responses–a “eugenic” vac­cine.
8.–The ani­mal tri­als have been severe­ly crit­i­cized: ” . . . . ‘This is the barest begin­ning of pre­lim­i­nary infor­ma­tion,’ said Dr. Gre­go­ry Poland, an immu­nol­o­gist and vac­cine researcher at the Mayo Clin­ic who has seen the paper, which has yet to under­go peer-review. Poland said the paper was incom­plete, dis­or­ga­nized and the num­bers of ani­mals test­ed were small. . . . Poland, who was not involved with the research, said the paper leaves out ‘impor­tant para­me­ters’ that could help sci­en­tists judge the work. . . .”
9.–The phase II clin­i­cal tri­als on humans are still under­way and won’t be com­plet­ed before Novem­ber.  Phase III is going to be get­ting under­way in July. The Human clin­i­cal tri­als are already under­way at the same time the ani­mal safe­ty tri­als have yet to be com­plet­ed.
10.–Side effects can take a while to man­i­fest.

We pro­vid­ed detailed crit­i­cal com­ments on Mod­er­na’s Phase I tri­al in FTR #1132.

We con­clude with a New York Times arti­cle sets forth a “Vac­cine Octo­ber Sur­prise” sce­nario for this fall.

” . . . . In a des­per­ate search for a boost, he could release a coro­n­avirus vac­cine that has not been shown to be safe and effec­tive as an Octo­ber sur­prise. Oct. 23, 2020, 9 a.m., with 10 days before the elec­tion, Fox New releas­es a poll show­ing Pres­i­dent Trump trail­ing Joe Biden by eight per­cent­age points. Oct. 23, 2020, 3 p.m., at a hasti­ly con­vened news con­fer­ence, Pres­i­dent Trump announces that the Food and Drug Admin­is­tra­tion has just issued an Emer­gency Use Autho­riza­tion for a coro­n­avirus vac­cine. Mr. Trump declares vic­to­ry over Covid-19, demands that all busi­ness­es reopen imme­di­ate­ly and pre­dicts a rapid eco­nom­ic recov­ery. Giv­en how this pres­i­dent has behaved, this incred­i­bly dan­ger­ous sce­nario is not far-fetched. In a des­per­ate search for a polit­i­cal boost, he could release a coro­n­avirus vac­cine before it had been thor­ough­ly test­ed and shown to be safe and effec­tive. . . .”

FTR #1130 Bio-Psy-Op Apocalypse Now, Part 6: The Magic Virus Theory, Part 3

In addi­tion to review­ing and high­light­ing cogent argu­ments that the SARS-Cov2 (Covid-19) virus may indeed have been made in a lab­o­ra­to­ry, the pro­gram exam­ines sig­nif­i­cant aspects of the hereto­fore puz­zling epi­demi­ol­o­gy of the virus. (We do NOT believe that the virus was syn­the­sized by Chi­na, as “Team Trump” is charg­ing.)

First, how­ev­er, the broad­cast sets forth infor­ma­tion about the quest for a Covid-19 vac­cine.

The make­up of Don­ald Trump’s “Oper­a­tion Warp Speed” pro­gram to devel­op a Covid-19 vac­cine in record time is alarm­ing. (No vac­cine has ever been devel­oped for human use in less than four years.)

“Oper­a­tion Warp Speed”:

1.–Is head­ed by Mon­cef Slaoui, for­mer­ly the chair­man of Mod­er­na’s prod­uct devel­op­ment com­mit­tee: ” . . . . Dr. Slaoui served on the board of Mod­er­na, a biotech­nol­o­gy com­pa­ny that has an exper­i­men­tal coro­n­avirus vac­cine that just entered Phase 2 of clin­i­cal tri­als to deter­mine if it is effec­tive. As the chair­man of the Mod­er­na board’s prod­uct devel­op­ment com­mit­tee, Dr. Slaoui might have been privy to the ear­ly indi­ca­tions of tests of whether the company’s approach appeared promis­ing, now that it is being inject­ed into human sub­jects. . . .”

2.–Is seen by Slaoui as promis­ing by Slaoui, who may well be ref­er­enc­ing tests on Mod­er­na’s mRNA vac­cine: “. . . . Dr. Slaoui, now a ven­ture cap­i­tal­ist, said that he had ‘recent­ly seen ear­ly data from a clin­i­cal tri­al with a coro­n­avirus vac­cine, and these data made me feel even more con­fi­dent that we will be able to deliv­er a few hun­dred mil­lion dos­es of vac­cine’ — enough to inoc­u­late much of the Unit­ed States — ‘by the end of 2020.’ . . . .”

3.–Will be assist­ed by a four-star gen­er­al: ” . . . . . . . . Mr. Slaoui will serve as the chief advis­er on the effort, and Gen. Gus­tave F. Per­na, a four-star gen­er­al who is in charge the Army Matériel Com­mand, will be the chief oper­at­ing offi­cer. . . .”

4.–Perna was recruit­ed by the Chair­man of the Joint Chiefs: ” . . . . Gen­er­al Per­na, who runs the Army’s com­plex sup­ply chain, said that he was asked by Gen. Mark A. Mil­ley, the chair­man of the Joint Chiefs of Staff, to help run the man­u­fac­tur­ing logis­tics relat­ed to the vac­cine devel­op­ment. . . .”

Note that Mon­cef Slaoui holds 10 mil­lion dol­lars worth of Mod­er­na stock, which has tripled in val­ue since the Covid-19 out­break began:” . . . . The for­mer phar­ma exec­u­tive tapped by Pres­i­dent Don­ald Trump to lead the fed­er­al gov­ern­men­t’s hunt for a COVID-19 vac­cine has more than $10 mil­lion in stock options in one of the com­pa­nies receiv­ing fed­er­al fund­ing. . . . Described across four sep­a­rate fil­ings, Slaoui has 155,438 options in Mod­er­na. The stake is worth $10,366,000 at Mod­er­na’s cur­rent share price, $66.69 at the time of pub­li­ca­tion. Mod­er­na shares have almost tripled in val­ue dur­ing 2020. The $66.69 fig­ure rep­re­sents an increase of  184% from the $23.46 it was trad­ing for on Jan­u­ary 1. . . .” (The day the pro­gram was record­ed, Mod­er­na’s stock increased by 25% in val­ue, and Slaoui announced he would sell his stock.)

In past posts and pro­grams, we have not­ed the Moderna–one of the com­pa­nies select­ed to devel­op a Covid-19 vac­cine, has been sub­stan­tial­ly under­writ­ten by the Pen­ta­gon (DARPA). 

Key points of dis­cus­sion in that regard:

1.–Moderna is using nov­el vac­cine tech­nol­o­gy using the injec­tion of genet­ic mate­r­i­al to cre­ate anti­bod­ies. This tech­nol­o­gy has nev­er been used on human beings. “. . . . The sec­ond phar­ma­ceu­ti­cal com­pa­ny that was select­ed by CEPI to devel­op a vac­cine for the new coro­n­avirus is Mod­er­na Inc., which will devel­op a vac­cine for the nov­el coro­n­avirus of con­cern in col­lab­o­ra­tion with the U.S. NIH and which will be fund­ed entire­ly by CEPI. The vac­cine in ques­tion, as opposed to Inovio’s DNA vac­cine, will be a mes­sen­ger RNA (mRNA) vac­cine. Though dif­fer­ent than a DNA vac­cine, mRNA vac­cines still use genet­ic mate­r­i­al ‘to direct the body’s cells to pro­duce intra­cel­lu­lar, mem­brane or secret­ed pro­teins.’ Moderna’s mRNA treat­ments, includ­ing its mRNA vac­cines, were large­ly devel­oped using a $25 mil­lion grant from DARPA and it often touts is strate­gic alliance with DARPA in press releas­es. . . .”

2.–The tech­nol­o­gy has alarm­ing pos­si­ble neg­a­tive side-effects. “. . . . Both DNA and mRNA vac­cines involve the intro­duc­tion of for­eign and engi­neered genet­ic mate­r­i­al into a person’s cells and past stud­ies have found that such vac­cines ‘pos­sess sig­nif­i­cant unpre­dictabil­i­ty and a num­ber of inher­ent harm­ful poten­tial haz­ards’ and that ‘there is inad­e­quate knowl­edge to define either the prob­a­bil­i­ty of unin­tend­ed events or the con­se­quences of genet­ic mod­i­fi­ca­tions.’ Nonethe­less, the cli­mate of fear sur­round­ing the coro­n­avirus out­break could be enough for the pub­lic and pri­vate sec­tor to devel­op and dis­trib­ute such con­tro­ver­sial treat­ments due to fear about the epi­dem­ic poten­tial of the cur­rent out­break. . . .”

3.–Looming large in the back­ground of the Mod­er­na vac­cine tech­nol­o­gy is DARPA fund­ing of “gene dri­ve” tech­nol­o­gy. “. . . . Con­cerns about Pen­ta­gon exper­i­ments with bio­log­i­cal weapons have gar­nered renewed media atten­tion, par­tic­u­lar­ly after it was revealed in 2017 that DARPA was the top fun­der of the con­tro­ver­sial ‘gene dri­ve’ tech­nol­o­gy, which has the pow­er to per­ma­nent­ly alter the genet­ics of entire pop­u­la­tions while tar­get­ing oth­ers for extinc­tion. At least two of DARPA’s stud­ies using this con­tro­ver­sial tech­nol­o­gy were clas­si­fied and ‘focused on the poten­tial mil­i­tary appli­ca­tion of gene dri­ve tech­nol­o­gy and use of gene dri­ves in agri­cul­ture,’ accord­ing to media reports. . . . Co-direc­tor of the ETC Group Jim Thomas said that this tech­nol­o­gy may be used as a bio­log­i­cal weapon: ‘Gene dri­ves are a pow­er­ful and dan­ger­ous new tech­nol­o­gy and poten­tial bio­log­i­cal weapons could have dis­as­trous impacts on peace, food secu­ri­ty and the envi­ron­ment, espe­cial­ly if mis­used, The fact that gene dri­ve devel­op­ment is now being pri­mar­i­ly fund­ed and struc­tured by the US mil­i­tary rais­es alarm­ing ques­tions about this entire field.’ . . . . How­ev­er, the ther­a­pies being devel­oped by Inovio, Mod­er­na and the Uni­ver­si­ty of Queens­land are in align­ment with DARPA’s objec­tives regard­ing gene edit­ing and vac­cine tech­nol­o­gy. For instance, in 2015, DARPA geneti­cist Col. Daniel Wat­ten­dorf described how the agency was inves­ti­gat­ing a ‘new method of vac­cine pro­duc­tion [that] would involve giv­ing the body instruc­tions for mak­ing cer­tain anti­bod­ies. Because the body would be its own biore­ac­tor, the vac­cine could be pro­duced much faster than tra­di­tion­al meth­ods and the result would be a high­er lev­el of pro­tec­tion.’ . . . .”

As dis­cussed in FTR #1124–among oth­er programs–it is now pos­si­ble to cre­ate ANY virus from scratch, using “mail-order” or “design­er” genes. In FTR #282–recorded in May of 2001–we not­ed the ter­ri­ble sig­nif­i­cance of the devel­op­ment of such “Design­er Gene” tech­nol­o­gy.

A BBC sto­ry from 1999 high­lights the fears of experts that the advent of such tech­nol­o­gy could enable the devel­op­ment of eth­no-spe­cif­ic bio­log­i­cal weapons: ” . . . . Advances in genet­ic knowl­edge could be mis­used to devel­op pow­er­ful bio­log­i­cal weapons that could be tai­lored to strike at spe­cif­ic eth­nic groups, the British Med­ical Asso­ci­a­tion has warned. A BMA report Biotech­nol­o­gy, Weapons and Human­i­ty says that con­cert­ed inter­na­tion­al action is nec­es­sary to block the devel­op­ment of new, bio­log­i­cal weapons.  . . . The BMA report warns that legit­i­mate research into micro­bi­o­log­i­cal agents and genet­i­cal­ly tar­get­ed ther­a­peu­tic agents could be dif­fi­cult to dis­tin­guish from research geared towards devel­op­ing more effec­tive weapons. . . . Dr Vivi­enne Nathanson, BMA Head of Health Pol­i­cy Research said:  ‘The his­to­ry of human­i­ty is a his­to­ry of war. Sci­en­tif­ic advances quick­ly lead to devel­op­ments in weapons tech­nol­o­gy. . . .‘Biotech­nol­o­gy and genet­ic knowl­edge are equal­ly open to this type of malign use. . . .”

We high­light infor­ma­tion pre­sent­ed in FTR #1129, for pur­pos­es of empha­siz­ing the flim­sy nature of the argu­ment pre­sent­ed in a paper from Nature Med­i­cine.

Many sci­en­tif­ic and med­ical peo­ple dis­miss­ing the argu­ment that the Covid-19 coro­n­avirus may have been cre­at­ed in a lab­o­ra­to­ry may be act­ing out of the sin­cere desire to pre­clude a full-dress Cold War between the U.S. and Chi­na. The Trump admin­is­tra­tion has tire­less­ly flogged the “Chi­na did it and it came from a lab­o­ra­to­ry” meme. Many lib­er­als who dis­missed the obvi­ous fact that Pres­i­dent Kennedy was mur­dered by a cabal of pow­er­ful U.S. nation­al secu­ri­ty inter­ests did so because of what Peter Dale Scott calls a “lev­el one cover-up”–alleged Sovi­et and/or Cas­tro Cuban manip­u­la­tion of Lee Har­vey Oswald, fab­ri­cat­ed by the exe­cu­tion­ers them­selves.

Two telling, thought­ful, sub­stan­tive cri­tiques of the Nature Med­i­cine arti­cle shed light on the flim­sy nature of its argu­ments.

It would not be unfair to char­ac­ter­ize the arti­cle as “The War­ren Report” of the Covid-19 pan­dem­ic.

Genet­ic Engi­neer­ing

Like the Bible, it is open to seri­ous sci­en­tif­ic refu­ta­tion: ” . . . . To put it sim­ply, the authors are say­ing that SARS-CoV­‑2 was not delib­er­ate­ly engi­neered because if it were, it would have been designed dif­fer­ent­ly. How­ev­er, the Lon­don-based mol­e­c­u­lar geneti­cist Dr Michael Anto­niou com­ment­ed that this line of rea­son­ing fails to take into account that there are a num­ber of lab­o­ra­to­ry-based sys­tems that can select for high affin­i­ty RBD vari­ants that are able to take into account the com­plex envi­ron­ment of a liv­ing organ­ism. This com­plex envi­ron­ment may impact the effi­cien­cy with which the SARS-CoV spike pro­tein can find the ACE2 recep­tor and bind to it. An RBD select­ed via these more real­is­tic real-world exper­i­men­tal sys­tems would be just as ‘ide­al’, or even more so, for human ACE2 bind­ing than any RBD that a com­put­er mod­el could pre­dict. And cru­cial­ly, it would like­ly be dif­fer­ent in amino acid sequence. So the fact that SARS-CoV­‑2 doesn’t have the same RBD amino acid sequence as the one that the com­put­er pro­gram pre­dict­ed in no way rules out the pos­si­bil­i­ty that it was genet­i­cal­ly engi­neered. . . .”

Dr. Michael Anto­niou notes that dif­fer­ent genet­ic engi­neer­ing process­es than the one high­light­ed in the Nature Med­i­cine paper can be used: ”  . . . . There is anoth­er method by which an enhanced-infec­tiv­i­ty virus can be engi­neered in the lab. A well-known alter­na­tive process that could have been used has the cum­ber­some name of “direct­ed iter­a­tive evo­lu­tion­ary selec­tion process”. In this case, it would involve using genet­ic engi­neer­ing to gen­er­ate a large num­ber of ran­dom­ly mutat­ed ver­sions of the SARS-CoV spike pro­tein recep­tor bind­ing domain (RBD), which would then be select­ed for strong bind­ing to the ACE2 recep­tor and con­se­quent­ly high infec­tiv­i­ty of human cells. . . .”

The notion that the “Nature Med­i­cine” authors had not heard of the above process is not cred­i­ble: ” . . . . Such a direct­ed iter­a­tive evo­lu­tion­ary selec­tion process is a fre­quent­ly used method in lab­o­ra­to­ry research. So there is lit­tle or no pos­si­bil­i­ty that the Nature Med­i­cine arti­cle authors haven’t heard of it – not least, as it is con­sid­ered so sci­en­tif­i­cal­ly impor­tant that its inven­tors were award­ed the Nobel Prize in Chem­istry in 2018. . . .”

Of more than pass­ing sig­nif­i­cance is anoth­er arti­cle that finds seri­ous fault with the “Nature Med­i­cine” paper. ” . . . . Pro­fes­sor Stu­art New­man, pro­fes­sor of cell biol­o­gy and anato­my at New York Med­ical Col­lege, says that a key argu­ment used to deny that it could be a genet­i­cal­ly engi­neered strain that escaped from a lab­o­ra­to­ry actu­al­ly points to the exact oppo­site. In oth­er words, it indi­cates that SARS-CoV­‑2 could well be genet­i­cal­ly engi­neered and that it could have escaped from a lab. . . . As Adam Lau­r­ing, an asso­ciate pro­fes­sor of micro­bi­ol­o­gy, immunol­o­gy and infec­tious dis­eases at the Uni­ver­si­ty of Michi­gan Med­ical School, has not­ed, Andersen’s paper argues that, ‘the SARS-CoV­‑2 virus has some key dif­fer­ences in spe­cif­ic genes rel­a­tive to pre­vi­ous­ly iden­ti­fied coro­n­avirus­es – the ones a lab­o­ra­to­ry would be work­ing with. This con­stel­la­tion of changes makes it unlike­ly that it is the result of a lab­o­ra­to­ry ‘escape’.‘But Pro­fes­sor New­man says that this is total­ly uncon­vinc­ing because ‘The ‘key dif­fer­ences’ were in regions of the coro­n­avirus spike pro­tein that were the sub­ject of genet­ic engi­neer­ing exper­i­ments in labs around the world (main­ly in the US and Chi­na) for two decades.’ . . .”

Pro­fes­sor New­man goes on to high­light oth­er, seri­ous flaws in the argu­ment: ” . . . In an email inter­view with GMWatch, New­man, who is edi­tor-in-chief of the jour­nal Bio­log­i­cal The­o­ry and co-author (with Tina Stevens) of the book Biotech Jug­ger­naut, ampli­fied this spec­u­la­tion by not­ing, ‘The Nature Med­i­cine paper points to vari­a­tions in two sites of the spike pro­tein of the new coro­n­avirus that the authors claim must have arisen by nat­ur­al selec­tion in the wild. How­ev­er, genet­ic engi­neer­ing of one of these sites, the ACE2 recep­tor bind­ing domain, has been pro­posed since 2005 in order to help gen­er­ate vac­cines against these virus­es (see this paper). It is puz­zling that the authors of the Nature Med­i­cine com­men­tary did not cite this paper, which appeared in the promi­nent jour­nal Sci­ence.’ More­over, New­man added, “The sec­ond site that Ander­sen et al. assert arose by nat­ur­al means, a tar­get of enzyme cleav­age not usu­al­ly found in this class of virus­es, was in fact intro­duced by genet­ic engi­neer­ing in a sim­i­lar coro­n­avirus in a paper they do cite. This was done to explore mech­a­nisms of path­o­genic­i­ty. . . . .”

Worth not­ing, again, is the British Med­ical Asso­ci­a­tion’s warn­ing dis­cussed in FTR #1129, as well as above: ” . . . .The BMA report warns that legit­i­mate research into micro­bi­o­log­i­cal agents and genet­i­cal­ly tar­get­ed ther­a­peu­tic agents could be dif­fi­cult to dis­tin­guish from research geared towards devel­op­ing more effec­tive weapons. . . .”

As the GMWatch authors con­clude: ” . . . . Such ‘enhanced infec­tiv­i­ty’ research is car­ried out on virus­es all over the world (and not just in Chi­na) to inves­ti­gate their behav­iour and to devel­op vac­cines and oth­er ther­a­pies, as well as for ‘biode­fence’ pur­pos­es. . . .”

Reports are now emerg­ing of pos­si­ble Covid-19 infec­tion among ath­letes who par­tic­i­pat­ed at the Mil­i­tary World Games in Wuhan in Octo­ber 19. 

We have spec­u­lat­ed at some length about the pos­si­bil­i­ty that infect­ing those very healthy, superbly-con­di­tioned indi­vid­u­als might have been an excel­lent vehi­cle for spread­ing the virus around the world. 

Fur­ther dis­cus­sion of this can be found in FTR #‘s 1118 and 1122. We note that Chi­na has spec­u­lat­ed about the Wuhan Mil­i­tary World Games being a vehi­cle for the U.S. to spread the infec­tion.

We have not­ed that lan­guage is, past a point, inad­e­quate to ana­lyze and dis­cuss some of the major con­sid­er­a­tions in the Covid-19 “op.” A bio-weapons would require a very small num­ber of agents in order to be effec­tive­ly dis­sem­i­nat­ed. In addi­tion, we note that–in the age of mind control–an oper­a­tive can be dis­pensed to per­form a func­tion with­out their knowl­edge.

In addi­tion to French ath­letes, con­tin­gents from Swe­den, Spain and Italy appear to have become infect­ed. The appar­ent infec­tion of the French ath­letes pre-dates the first con­firmed case in Chi­na by 20 days.

A fish mer­chant who worked near Charles De Gaulle Air­port test­ed pos­i­tive for the virus on Decem­ber 27.

The appar­ent­ly infect­ed ath­letes par­tic­i­pat­ing in the Mil­i­tary World Games fur­ther com­pli­cates the puz­zling epi­demi­ol­o­gy of the virus.

Doc­tors quot­ed in a New York Times piece under­score the anom­alous epi­demi­ol­o­gy of the virus: ” . . . . In San Jose, tis­sue sam­pling from a woman who died on Feb. 6 revealed that she was prob­a­bly the first known per­son in the U.S. whose death was linked to the coro­n­avirus — a strong sign that the virus may have been cir­cu­lat­ing in that part of North­ern Cal­i­for­nia in Jan­u­ary. But was it part of a large, pre­vi­ous­ly unrec­og­nized out­break? . . .

“. . . . Dr. George Ruther­ford, a pro­fes­sor of epi­demi­ol­o­gy and bio­sta­tis­tics at the Uni­ver­si­ty of Cal­i­for­nia, San Fran­cis­co, the­o­rized that per­haps the woman, who worked for a com­pa­ny that had an office in Wuhan, was one of only a small num­ber of peo­ple who con­tract­ed the virus at that time and that trans­mis­sions prob­a­bly petered out for some rea­son. Oth­er­wise, he said, the region would have seen a much big­ger out­break. . . .

“. . . . Dr. [Trevor] Bed­ford said he also believed this was the more like­ly sce­nario, not­ing that up to half of peo­ple with coro­n­avirus infec­tions have no symp­toms. . . .

“. . . . There could have been a tiny num­ber of iso­lat­ed coro­n­avirus cas­es among trav­el­ers to the Unit­ed States in Decem­ber, Dr. Bed­ford said. But it is pret­ty clear that none of them spread.

“In part, sci­en­tists can tell that by look­ing at the genom­ic fin­ger­prints of each case. But anoth­er clue is the rapid rate at which the virus spreads, Dr. Ruther­ford said. . . . Researchers are not see­ing any chains that appear to go that far back. . . .”

Lead­ing the Trump admin­is­tra­tion’s rhetor­i­cal and polit­i­cal charge against Chi­na is Mike Pom­peo. Charg­ing that the virus “escaped” from a lab in Wuhan and equiv­o­cat­ing about whether that release was inten­tion­al, Koch broth­ers-pro­tege Pom­peo cit­ed alleged duplic­i­ty on behalf of Chi­na’s com­mu­nist par­ty in con­nec­tion with the virus. ” . . . . ‘I can tell you that there is a sig­nif­i­cant amount of evi­dence that this came from that lab­o­ra­to­ry in Wuhan,’ Pom­peo said on ABC’s ‘This Week’ Sun­day. ‘Do you think they inten­tion­al­ly released that virus, or it was an acci­dent in the lab?’ Co-Anchor Martha Rad­datz pressed. ‘I can’t answer your ques­tion about that,’ he said, ‘because the Chi­nese Com­mu­nist Par­ty has refused to coop­er­ate with world health experts.’ . . .”

The Chi­nese med­ical and sci­en­tif­ic estab­lish­ment has worked close­ly with coun­ter­parts glob­al­ly in an attempt to ana­lyze and treat the virus.

The high­ly anom­alous epi­demi­ol­o­gy, the lack of symp­toms in half of infect­ed patients, the wide vari­ety of symp­toms the virus caus­es and, last­ly, the fact that this was a nov­el virus and result­ing infec­tion are all fac­tors to be con­sid­ered in eval­u­at­ing the time­li­ness of the Chi­nese response.

Pom­peo also asserts that the virus was not made in a lab­o­ra­to­ry.

Next, we high­light a mis­lead­ing sto­ry in Rupert Mur­doch’s “The Dai­ly Tele­graph” out of Syd­ney, Aus­tralia. The sto­ry alleges that the Five Eyes elec­tron­ic intel­li­gence net­work has cor­rob­o­rat­ed the “it came from a Chi­nese lab” meme.

Of more than pass­ing inter­est is the dis­clo­sure that the project on bat-borne coro­n­avirus­es con­duct­ed in the Wuhan lab­o­ra­to­ry was a joint U.S./Chinese project, and that Ralph Bar­ic was a key Amer­i­can part­ner in the project.

This is the under­tak­ing about which we have report­ed and dis­cussed exten­sive­ly in the past! ” . . . . One of Dr Shi’s co-authors on that paper, Pro­fes­sor Ralph Bar­ic from North Car­oli­na Uni­ver­si­ty, said in an inter­view with ‘Sci­ence Dai­ly’ at the time: ‘This virus is high­ly path­o­gen­ic and treat­ments devel­oped against the orig­i­nal SARS virus in 2002 and the ZMapp drugs used to fight ebo­la fail to neu­tralise and con­trol this par­tic­u­lar virus.’ . . . .”

Bar­ic was the selectee to recon­struct the SARS Cov2 virus from scratch. Note that the arti­cle below dis­cuss­es the U.S. sus­pen­sion of the “gain of func­tion” exper­i­ments and 2017 resump­tion of same, some­how spin­ning this into the “Chi­na did it” dis­in­for­ma­tion.

The mil­i­tary has links to the Wuhan lab in ques­tion: ” . . . . Fur­ther­more, DARPA and the Pentagon’s past his­to­ry with bioweapons and their more recent exper­i­ments on genet­ic alter­ation and extinc­tion tech­nolo­gies as well as bats and coro­n­avirus­es in prox­im­i­ty to Chi­na have been large­ly left out of the nar­ra­tive, despite the infor­ma­tion being pub­licly avail­able. Also left out of the media nar­ra­tive have been the direct ties of both the USAMRIID and DARPA-part­nered Duke Uni­ver­si­ty to the city of Wuhan, includ­ing its Insti­tute of Med­ical Virol­o­gy. . . .”

A “Guardian” arti­cle sources UK intel­li­gence assets claim­ing that the 15-page dossier didn’t come from a Five Eyes intel­li­gence assess­ment. They assert that it was based on open-source mate­ri­als and put for­ward by the US as “a tool for build­ing a counter-nar­ra­tive and apply­ing pres­sure to Chi­na.”

We con­clude with analy­sis of Trump’s deputy nation­al secu­ri­ty advis­er.

Against the back­ground of the Trump admin­is­tra­tion’s anti-Chi­na cam­paign rhetoric and attempts to pin the blame for Covid-19 on a “lab­o­ra­to­ry” leak and/or delib­er­ate release, we note that the offen­sive is being pushed by The Don­ald’s deputy nation­al secu­ri­ty advis­er Matthew Pot­tinger.

“. . . . Matthew Pot­tinger, the deputy nation­al secu­ri­ty advis­er who report­ed on SARS out­breaks as a jour­nal­ist in Chi­na, pressed intel­li­gence agen­cies in Jan­u­ary to gath­er infor­ma­tion that might sup­port any ori­gin the­o­ry linked to a lab. . . .”

Pot­tinger is the son of for­mer Assis­tant Attor­ney Gen­er­al J. Stan­ley Pot­tinger.

Pot­tinger, Senior was: Assis­tant Attor­ney Gen­er­al for Civ­il Rights under Nixon and Ford; report­ed by Don­ald Freed and Fred Lan­dis (in “Death in Wash­ing­ton”) to have foiled inves­ti­ga­tions into the assas­si­na­tions of Mar­tin Luther King and Orlan­do Lete­lier; the attor­ney for the Hashe­mi broth­ers in the Octo­ber Sur­prise inves­ti­ga­tion; a close per­son­al friend of George H.W. Bush (for whom CIA head­quar­ters was named) and, last but cer­tain­ly not least, Glo­ria Steinem’s lover for nine years.

Despite the fact that Steinem tout­ed her CIA back­ground as good jour­nal­is­tic cre­den­tials in both “The New York Times” and “The Wash­ing­ton Post” (both with long-stand­ing CIA links them­selves), Pot­tinger has defend­ed her against charges that she worked for the CIA!!

Worth not­ing, as well, is the fact that the Lete­lier assas­si­na­tion was one of the mur­ders con­duct­ed under Oper­a­tion Con­dor, assist­ed by the CIA. Lete­lier was killed by a car bomb in Wash­ing­ton D.C., while J.Stanley Pot­tinger’s good friend George H.W. Bush was in charge of the CIA when Lete­lier was hit.

(We have cov­ered Oper­a­tion Con­dor in numer­ous pro­grams, includ­ing AFA #19. One of the oper­a­tional cen­ters of Con­dor was the Chilean Nazi enclave Colo­nia Dig­nidad. In FTR #839, we set forth author Peter Lev­en­da’s brave, fright­en­ing vis­it to “The Colony.” This should be digest­ed by any­one inter­est­ed in the his­to­ry of which Pot­tinger, Sr., is a part.)

One won­ders if Matthew may have fol­lowed J. Stan­ley into the CIA, if in fact Dad­dio is Agency, as Mr. Emory sus­pects.

In FTR #s 998, 999, 1000, we set forth what Mr. Emory calls “weaponized fem­i­nism.” Refash­ion­ing the doc­trine of advanc­ing the cause of women into a legal and polit­i­cal weapon for destroy­ing tar­get­ed men, dom­i­nant man­i­fes­ta­tions of the #MeToo move­ment have served the cause of the far right.

Resembling–in its essence–the “libid­i­nal McCarthy­ism” of Arthur Miller’s play “The Cru­cible,”  many high-pro­file man­i­fes­ta­tions of #MeToo have been pro­pelled by evi­den­tiary mate­r­i­al that ranges from dubi­ous to ludi­crous to non-exis­tent.

We find it more than coin­ci­den­tal that Bernie Sanders sup­port­er Tara Read­e’s shape-shift­ing accu­sa­tions against Joe Biden have sur­faced decades after the alleged incident–coinciding with Biden’s chal­leng­ing of Trump and with Pot­tinger, Jr. help­ing to direct the admin­is­tra­tion’s traf­fic.

Pottinger Agonistes: Covid-19 Disinformation Meets Weaponized Feminism

“A lib­er­al’s idea of courage is eat­ing at a restau­rant that has­n’t been reviewed yet.”–Mort Sahl. In FTR #‘s 998, 999 and 1000, we set forth what Mr. Emory calls “weaponized fem­i­nism.” Refash­ion­ing the doc­trine of advanc­ing the cause of women into a legal and polit­i­cal weapon for destroy­ing tar­get­ed men, dom­i­nant man­i­fes­ta­tions of the #MeToo move­ment have served the cause of the far right. In Mis­cel­la­neous Archive Show M4, we set forth Glo­ria Steinem’s work for the CIA and her nine years’ rela­tion­ship with J. Stan­ley Pot­tinger. In addi­tion to Steinem’s lover, Pot­tinger was: Assis­tant Attor­ney Gen­er­al for Civ­il Rights under Nixon and Ford; report­ed by Don­ald Freed and Fred Lan­dis (in “Death in Wash­ing­ton”) to have foiled inves­ti­ga­tions into the assas­si­na­tions of Mar­tin Luther King and Orlan­do Lete­lier; the attor­ney for the Hashe­mi broth­ers in the Octo­ber Sur­prise inves­ti­ga­tion and a close per­son­al friend of George H.W. Bush (for whom CIA head­quar­ters was named). Despite the fact that Steinem tout­ed her CIA back­ground as good jour­nal­is­tic cre­den­tials in both “The New York Times” and “The Wash­ing­ton Post” (both with long-stand­ing CIA links them­selves), Pot­tinger has defend­ed her against charges that she worked for the CIA!! J. Stan­ley Pot­tinger’s son Matthew is Trump’s Deputy Nation­al Secu­ri­ty Advi­sor and a point-man for the “Chi­na-did-it” Covid-19 meme. One won­ders if Matthew may have fol­lowed J. Stan­ley into the CIA, if in fact Dad­dio is Agency, as Mr. Emory sus­pects. We find it more than coin­ci­den­tal that Tara Read­e’s shape-shift­ing accu­sa­tions against Joe Biden have sur­faced decades after the alleged incident–coinciding with Biden’s chal­leng­ing of Trump and with Pot­tinger, Jr. help­ing to direct the admin­is­tra­tion’s traf­fic. Bernie Sanders sup­port­er Tara Read­e’s charge brings to mind George H.W. Bush cam­paign man­ag­er Lee Atwa­ter’s gam­bit of using Don­na Rice to destroy the Pres­i­den­tial can­di­da­cy of for­mer Sen­a­tor Gary Hart.

FTR #1026 The So-Called “Arab Spring” Revisited, Part 2

In FTR #‘s 733 through 739, we pre­sent­ed our view that the so-called Arab Spring was a U.S. intel­li­gence oper­a­tion, aimed at plac­ing the Broth­er­hood in pow­er in Mus­lim coun­tries dom­i­nat­ed either by a sec­u­lar dic­ta­tor or absolute monar­chy.

Con­tin­u­ing analy­sis from our pre­vi­ous pro­gram, this broad­cast delves fur­ther into the net­work­ing between the Mus­lim Broth­er­hood and Al-Qae­da. Against the back­ground of the occu­pa­tion of Idlib Province in Syr­ia by Al-Qae­da, we high­light the appar­ent role of Mor­si’s gov­ern­ment and the Mus­lim Broth­er­hood in the events sur­round­ing the 2012 attack on the U.S. Embassy in Beng­hazi, Libya.

The over­throw of Khadafy in Libya was an out­growth of the so-called Arab Spring, as was the pre­cip­i­ta­tion of the civ­il war in Syr­ia. Of par­tic­u­lar sig­nif­i­cance is the fact that the GOP-led inves­ti­ga­tions of the Beng­hazi attack led direct­ly to both the inves­ti­ga­tion of Hillary Clin­ton’s e‑mails and the deci­sive­ly sig­nif­i­cant FBI tam­per­ing with the 2016 elec­tion, as well as the alleged “hack” of Hillary’s e‑mails!

An Egypt­ian news­pa­per pub­lished what were said to be inter­cept­ed record­ings of Mor­si com­mu­ni­cat­ing con­spir­a­to­ri­al­ly with Muham­mad al-Zawahiri, the the broth­er of Ayman al-Zawahiri, the head of Al-Qae­da. Much of this checks out with infor­ma­tion that is already on the pub­lic record.

Note the net­work­ing of GOP Sen­a­tors John McCain and Lind­say Gra­ham with Khairat El-Shater of the Egypt­ian Mus­lim Broth­er­hood while he was in prison, as well as the alleged links between the Egypt­ian Broth­er­hood and the cells involved in attack­ing the U.S. Embassy in Libya.

What we may well be look­ing at is a gam­bit along the lines of what has become known as the Octo­ber Surprise–collusion between the Iran­ian Islamists and George H.W. Bush/CIA/GOP to (among oth­er things) desta­bi­lize the Carter admin­is­tra­tion and 1980 re-elec­tion cam­paign.

In addi­tion, we won­der about a deal hav­ing been struck to have Al-Qae­da fight against Bashar Assad in Syr­ia, while avoid­ing attacks inside the U.S.?

Of pri­ma­ry focus in the mate­r­i­al below is Khairat El-Shater (translit­er­at­ed spellings of his name dif­fer.) El-Shater:

1.–Was the num­ber two man in the Mus­lim Broth­er­hood, though not for­mer­ly a mem­ber of Mor­si’s gov­ern­ment.
2.–Networked with U.S. Ambas­sador Anne Pat­ter­son and GOP Sen­a­tors John McCain and Lind­say Gra­ham and Khairat El-Shater (alter­na­tive­ly translit­er­at­ed with two “t’s” and/or an “al”), short­ly after Mor­si was deposed. ” . . . . It is inter­est­ing to note here that, pri­or to these rev­e­la­tions, U.S. ambas­sador Anne Pat­ter­son was seen vis­it­ing with Khairat El-Shater—even though he held no posi­tion in the Mor­si government—and after the oust­ing and impris­on­ment of Mor­si and lead­ing Broth­er­hood mem­bers, Sens. John McCain and Lind­say Gra­ham made it a point to vis­it the civil­ian Shater in his prison cell and urged the Egypt­ian gov­ern­ment to release him. . . .”
3.–Was deeply involved in mobi­liz­ing Al-Qae­da on behalf of Mor­si and the Broth­er­hood: ” . . . . Also on that same first day of the rev­o­lu­tion, Khairat al-Shater, Deputy Leader of the Broth­er­hood, had a meet­ing with a del­e­gate of jiha­di fight­ers and reit­er­at­ed Morsi’s request that all jihadis come to the aid of the pres­i­den­cy and the Broth­er­hood. . . . ”
4.–Was the appar­ent source of a $50 mil­lion con­tri­bu­tion by the Broth­er­hood to Al Qae­da: ” . . . . That the Mus­lim Brotherhood’s inter­na­tion­al wing, includ­ing through the agency of Khairat al-Shater, had pro­vid­ed $50 mil­lion to al-Qae­da in part to sup­port the Mus­lim Broth­er­hood in Egypt. . . .”
5.–Had the pass­port of the alleged leader of the Beng­hazi attack in his home when he was arrest­ed: ” . . . . Most recent­ly, on July 29, 2013, Ahmed Musa, a promi­nent Egypt­ian polit­i­cal insid­er and ana­lyst made sev­er­al asser­tions on Tahrir TV that fur­ther con­nect­ed the dots. . . . Musa insist­ed that he had absolute knowl­edge that the mur­der­er of Chris Stevens was Mohsin al-‘Azzazi, whose pass­port was found in Broth­er­hood leader Khairat El-Shater’s home, when the lat­ter was arrest­ed. . . .”
6.–Epitomized the GOP-beloved, cor­po­ratist eco­nom­ic ide­ol­o­gy and lifestyle: ” . . . . Arguably the most pow­er­ful man in the Mus­lim Broth­er­hood is Khairat El-Shater, a mul­ti­mil­lion­aire tycoon whose finan­cial inter­ests extend into elec­tron­ics, man­u­fac­tur­ing and retail. A strong advo­cate of pri­va­ti­za­tion, Al-Shater is one of a cadre of Mus­lim Broth­er­hood busi­ness­men who helped finance the Brotherhood’s Free­dom and Jus­tice Party’s impres­sive elec­toral vic­to­ry this win­ter and is now craft­ing the FJP’s eco­nom­ic agen­da. . . . . . . . the Brotherhood’s ide­ol­o­gy actu­al­ly has more in com­mon with America’s Repub­li­can Par­ty than with al-Qai­da. Few Amer­i­cans know it but the Broth­er­hood is a free-mar­ket par­ty led by wealthy busi­ness­men whose eco­nom­ic agen­da embraces pri­va­ti­za­tion and for­eign invest­ment while spurn­ing labor unions and the redis­tri­b­u­tion of wealth. Like the Repub­li­cans in the U.S., the finan­cial inter­ests of the party’s lead­er­ship of busi­ness­men and pro­fes­sion­als diverge sharply from those of its poor, social­ly con­ser­v­a­tive fol­low­ers. . . .”

This broad­cast begins with con­clu­sion of read­ing of a key arti­cle that was fea­tured in our last pro­gram.

Key points of analy­sis in dis­cus­sion of the Morsi/Zawahiri/Brotherhood con­nec­tion include:

1.–Muhamed Zawahir­i’s promise to bol­ster Mor­si’s gov­ern­ment with mil­i­tary sup­port, in exchange for Mor­si steer­ing Egypt in the direc­tion of Sharia law. ” . . . . The call end­ed in agree­ment that al-Qae­da would sup­port the Broth­er­hood, includ­ing its inter­na­tion­al branch­es, under the under­stand­ing that Mor­si would soon imple­ment full Sharia in Egypt.  After this, Muham­mad Zawahiri and Khairat al-Shater, the num­ber-two man of the Mus­lim Broth­er­hood orga­ni­za­tion, report­ed­ly met reg­u­lar­ly. . . .”
2.–Morsi’s agree­ment with Zawahir­i’s pro­pos­al. ” . . . . Zawahiri fur­ther request­ed that Mor­si allow them to devel­op train­ing camps in Sinai in order to sup­port the Broth­er­hood through trained mil­i­tants. Along with say­ing that the Broth­er­hood intend­ed to form a ‘rev­o­lu­tion­ary guard’ to pro­tect him against any coup, Mor­si added that, in return for al-Qaeda’s and its affil­i­ates’ sup­port, not only would he allow them to have such train­ing camps, but he would facil­i­tate their devel­op­ment in Sinai and give them four facil­i­ties to use along the Egypt­ian-Libyan bor­der. . . .”
3.–The net­work­ing between U.S. Ambas­sador Anne Pat­ter­son and GOP Sen­a­tors John McCain and Lind­say Gra­ham and Khairat El-Shater (alter­na­tive­ly translit­er­at­ed with two “t’s”), short­ly after Mor­si was deposed. ” . . . . It is inter­est­ing to note here that, pri­or to these rev­e­la­tions, U.S. ambas­sador Anne Pat­ter­son was seen vis­it­ing with Khairat al-Shater—even though he held no posi­tion in the Mor­si government—and after the oust­ing and impris­on­ment of Mor­si and lead­ing Broth­er­hood mem­bers, Sens. John McCain and Lind­say Gra­ham made it a point to vis­it the civil­ian Shater in his prison cell and urged the Egypt­ian gov­ern­ment to release him. . . .”
4.–Note that Mor­si sanc­tioned and Broth­er­hood-aid­ed Al-Qae­da mil­i­tants were appar­ent­ly involved in the Behg­hazi attacks that led to the Beng­hazi inves­ti­ga­tion, the Hillary e‑mails non-scan­dal and all that fol­lowed: ” . . . . Accord­ing to a Libyan Ara­bic report I trans­lat­ed back in June 2013, those who attacked the U.S. con­sulate in Beng­hazi, killing Amer­i­cans, includ­ing Ambas­sador Chris Stevens, were from jiha­di cells that had been formed in Libya through Egypt­ian Mus­lim Broth­er­hood sup­port.  Those inter­ro­gat­ed named Mor­si and oth­er top Broth­er­hood lead­er­ship as accom­plices. . . . ”
5.–Khairat El-Shater was deeply involved in mobi­liz­ing Al-Qae­da on behalf of Mor­si and the Broth­er­hood: ” . . . . Also on that same first day of the rev­o­lu­tion, Khairat al-Shater, Deputy Leader of the Broth­er­hood, had a meet­ing with a del­e­gate of jiha­di fight­ers and reit­er­at­ed Morsi’s request that all jihadis come to the aid of the pres­i­den­cy and the Broth­er­hood. . . . ”
6.–Khairat El-Shater was the appar­ent source of a $50 mil­lion con­tri­bu­tion by the Broth­er­hood to Al Qae­da: ” . . . . That the Mus­lim Brotherhood’s inter­na­tion­al wing, includ­ing through the agency of Khairat al-Shater, had pro­vid­ed $50 mil­lion to al-Qae­da in part to sup­port the Mus­lim Broth­er­hood in Egypt. . . .”
7.–Next, we high­light anoth­er impor­tant arti­cle from Ray­mond Ibrahim about the Mor­si/Al-Qae­da con­nec­tion to the Beng­hazi attack. Sup­ple­ment­ing the infor­ma­tion about net­work­ing between U.S. Ambas­sador to Egypt Anne Pat­ter­son, John McCain, Lind­say Gra­ham and Khairat al-Shater, we note that:

1.–The Beng­hazi attack­ers were appar­ent­ly linked to Mor­si and the Broth­er­hood: ” . . . . days after the Beng­hazi attack back in Sep­tem­ber 2012, Mus­lim Broth­er­hood con­nec­tions appeared.  A video made dur­ing the con­sulate attack records peo­ple approach­ing the belea­guered U.S. com­pound; one of them yells to the besiegers in an Egypt­ian dialect, ‘Don’t shoot—Dr. Mor­si sent us!’ appar­ent­ly a ref­er­ence to the for­mer Islamist pres­i­dent. . . .”
2.–The pass­port of the alleged leader of the Beng­hazi attack was found in the home of McCain/Graham con­tact Kharat al-Shater’s home when he was arrest­ed: ” . . . . Most recent­ly, on July 29, 2013, Ahmed Musa, a promi­nent Egypt­ian polit­i­cal insid­er and ana­lyst made sev­er­al asser­tions on Tahrir TV that fur­ther con­nect­ed the dots. . . . Musa insist­ed that he had absolute knowl­edge that the mur­der­er of Chris Stevens was Mohsin al-‘Azzazi, whose pass­port was found in Broth­er­hood leader Khairat El-Shater’s home, when the lat­ter was arrest­ed. . . .”
3.–The attack on the U.S. Embassy may well have been intend­ed to take Chris Stevens hostage, in order to use him as poten­tial barter for the Blind Sheikh: ” . . . . The day before the embassy attacks, based on lit­tle known but legit­i­mate Ara­bic reports, I wrote an arti­cle titled ‘Jihadis Threat­en to Burn U.S. Embassy in Cairo,’ explain­ing how Islamists—including al-Qaeda—were threat­en­ing to attack the U.S. embassy in Cairo unless the noto­ri­ous Blind Sheikh—an Islamist hero held in prison in the U.S. in con­nec­tion to the first World Trade Cen­ter bombing—was released.  The date Sep­tem­ber 11 was also delib­er­ate­ly cho­sen to attack the embassy to com­mem­o­rate the ‘hero­ic’ Sep­tem­ber 11, 2001 al-Qae­da strikes on Amer­i­ca. . . .”
4.–The Unit­ed States: ” . . . . first with Anne Pat­ter­son, and now with Sen­a­tors John McCain and Lind­say Gra­ham, keep pres­sur­ing Egypt to release Broth­er­hood lead­ers; McCain per­son­al­ly even vis­it­ed the civil­ian El-Shater, whose raid­ed home revealed the pass­port of Azzazi, whom Musa claims is the mur­der­er of Stevens. . . .”

Fol­low­ing the Beng­hazi dis­cus­sion, we recap an arti­cle about the Broth­er­hood and appar­ent Al-Qaeda/Beng­hazi col­lab­o­ra­tor Khairat El-Shater, not­ing the pow­er­ful res­o­nance between his and the Mus­lim Broth­er­hood’s val­ues and those of the GOP and the cor­po­rate com­mu­ni­ty:

1.–” . . . . the Brotherhood’s ide­ol­o­gy actu­al­ly has more in com­mon with America’s Repub­li­can Par­ty than with al-Qai­da. Few Amer­i­cans know it but the Broth­er­hood is a free-mar­ket par­ty led by wealthy busi­ness­men whose eco­nom­ic agen­da embraces pri­va­ti­za­tion and for­eign invest­ment while spurn­ing labor unions and the redis­tri­b­u­tion of wealth. Like the Repub­li­cans in the U.S., the finan­cial inter­ests of the party’s lead­er­ship of busi­ness­men and pro­fes­sion­als diverge sharply from those of its poor, social­ly con­ser­v­a­tive fol­low­ers. . . .”
2.–” . . . . Arguably the most pow­er­ful man in the Mus­lim Broth­er­hood is Khairat El-Shater, a mul­ti­mil­lion­aire tycoon whose finan­cial inter­ests extend into elec­tron­ics, man­u­fac­tur­ing and retail. A strong advo­cate of pri­va­ti­za­tion, Al-Shater is one of a cadre of Mus­lim Broth­er­hood busi­ness­men who helped finance the Brotherhood’s Free­dom and Jus­tice Party’s impres­sive elec­toral vic­to­ry this win­ter and is now craft­ing the FJP’s eco­nom­ic agen­da. . . .”

We con­clude with infor­ma­tion about the train­ing of activists in high-tech and social media in order to launch the Arab Spring.

In a remark­able and very impor­tant new book, Yasha Levine has high­light­ed the role of U.S. tech per­son­nel in train­ing and prep­ping the Arab Spring online activists.

Note while read­ing the fol­low­ing excerpts of this remark­able and impor­tant book, that:

1.–The Tor net­work was devel­oped by, and used and com­pro­mised by, ele­ments of U.S. intel­li­gence.
2.–One of the pri­ma­ry advo­cates and spon­sors of the Tor net­work is the Broad­cast­ing Board of Gov­er­nors. As we saw in FTR #‘s 891, 895, is an exten­sion of the CIA.
3.–Jacob Appel­baum has been financed by the Broad­cast­ing Board of Gov­er­nors, advo­cates use of the Tor net­work, has helped Wik­iLeaks with its exten­sive use of the Tor net­work, and is a the­o­ret­i­cal accolyte of Ayn Rand.

Custom Search

FROM THE LECTURE SERIES

UFOThe Political Implications of the UFO Phenomenon and the "ET" Myth Exposes U.S. intelligence influence behind the "brothers from space" industry. Read more »